home / stock / anix / anix news


ANIX News and Press, Anixa Biosciences Inc. From 01/05/21

Stock Information

Company Name: Anixa Biosciences Inc.
Stock Symbol: ANIX
Market: NASDAQ
Website: anixa.com

Menu

ANIX ANIX Quote ANIX Short ANIX News ANIX Articles ANIX Message Board
Get ANIX Alerts

News, Short Squeeze, Breakout and More Instantly...

ANIX - Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference PR Newswire SAN JOSE, Calif. , Jan. 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and in...

ANIX - MARA, PTON, QS and VLDR among premarket gainers

Aurora Mobile (JG) +85% after company inks partnership with new EV manufactures.Aemetis (AMTX) +61% after company acquired ~20% ownership of Nevo Motors.Hudson Capital (HUSN) +40% after issuing revenue guidance for FreightHub.Sportsman's Warehouse Holdings (SPWH)...

ANIX - Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine Novel technology developed by Cleveland Clinic researchers PR Newswire SAN JOSE, Calif. , Dec. 21, 2020 /PRNewswire/ -- Anixa Biosciences, Inc....

ANIX - Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing SAN JOSE, Calif. , Dec. 14, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of c...

ANIX - Lloyds Banking Group, Barclays leads premarket losers' pack

Nabriva Therapeutics NBRV -30% after priced $15M public offering.Aytu BioScience (AYTU) -25% on raising 'bought deal' offering to $25M.Immutep (IMMP) -24%.Professional Diversity Network (IPDN) -24%.SELLAS Life Sciences Group SLS -21% after announcing positiv...

ANIX - Immutep, Greenwich LifeSciences leads healthcare gainers; Xenetic Biosciences, Oncternal Therapeutics among major losers

Gainers: Immutep (IMMP) +204%, Greenwich LifeSciences (GLSI) +60%, TG Therapeutics (TGTX) +37%, SELLAS Life Sciences (SLS) +28%, Anixa Biosciences (ANIX) +18%.Losers: Xenetic Biosciences (XBIO) -32%, Oncternal Therapeutics (ONCT)-26%, GeoVax L...

ANIX - Anixa Biosciences, Cleveland Clinic in ovarian cancer vaccine pact

Anixa Biosciences ([[ANIX]] +4.5%) has entered into a license agreement with Cleveland Clinic for exclusive, world-wide rights to an ovarian cancer vaccine technology. The development-stage vaccine targets the extracellular domain of anti-mullerian hormone receptor 2 (AMHR2-ED), that appears ...

ANIX - Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology Anixa to Host a Conference Call Thursday, December 3, 2020, 1:15 p.m. PT to Discuss Program PR Newswire SAN JOSE, Calif., Dec. 1, 2020 SAN JOSE, Calif. ...

ANIX - Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine PR Newswire SAN JOSE, Calif., Nov. 23, 2020 SAN JOSE, Calif. , Nov. 23, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on t...

ANIX - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadThe earnings season marches on even as investors head into next week with a fair amount of uncertainty on election scenar...

Previous 10 Next 10